Piramal completes sale of formulations business to Abbott Healthcare
This article was originally published in Scrip
Executive Summary
Shares of Piramal Healthcare moved up on Indian bourses following news that it had completed the sale of its domestic formulations business to Abbott Healthcare, less than four months after the transaction was first announced.